The association between EP300 (EP300 Lysine Acetyltransferase) and Rubinstein-Taybi Syndrome 2 is well established and manually curated, with its 4 contributing sources — 3 of them expert-curated — recording a known molecular basis, pathogenic and likely-pathogenic variants, and a causative germline mutation.
Sources4
Clinical variants1,240
Symptoms172
Compounds0
Trials0
Publications28
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.